| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44013570 | HTLV-1 | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
| TVIS44011234 | HTLV-1 | ENSG00000159110.22 | protein_coding | IFNAR2 | No | No | 3455 | P48551 Q9BUA0 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | IFNAR2 |
|---|---|
| DrugBank ID | DB00069 |
| Drug Name | Interferon alfacon-1 |
| Target ID | BE0000385 |
| UniProt ID | P48551 |
| Regulation Type | binder |
| PubMed IDs | 8836913; 12528473; 11752352 |
| Citations | Blatt LM, Davis JM, Klein SB, Taylor MW: The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res. 1996 Jul;16(7):489-99.@@Yasuda S, Miyata K: [Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile]. Nihon Yakurigaku Zasshi. 2002 Dec;120(6):421-6.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA164749376 |
| ChEMBL | CHEMBL1201557 |
